SYNERGY has obtained the European Pharmacopoeia Adaptation Certificate
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, SYNERGY (300636.SZ) announced that the company recently received the revised Certificate of Suitability (CEP) for Ticagrelor active pharmaceutical ingredient from the European Directorate for the Quality of Medicines (EDQM). The main reason for this revision is the addition of a new production workshop, and the certification scope is: Ticagrelor active pharmaceutical ingredient. The revised certificate will be effective from September 12, 2025